phosphorylcholine has been researched along with u 0126 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Saffar, NM; Beloueche-Babari, M; Jackson, LE; Leach, MO; Ronen, SM; Workman, P | 1 |
| Jeon, ES; Kim, JH; Lee, MJ; Sung, SM | 1 |
| Jeon, ES; Kim, JH; Kim, YM; Lee, MJ; Moon, HJ; Oh, CK | 1 |
| Lodi, A; Ronen, SM; Woods, SM | 1 |
| Cartagena-Rivera, AX; Chadwick, RS; Logue, JS | 1 |
5 other study(ies) available for phosphorylcholine and u 0126
| Article | Year |
|---|---|
Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.
Topics: Biomarkers, Tumor; Breast Neoplasms; Butadienes; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Inhibitors; HCT116 Cells; Humans; Magnetic Resonance Spectroscopy; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylcholine | 2005 |
Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK.
Topics: Animals; Apoptosis; Blotting, Western; Butadienes; Caspase 3; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; In Situ Nick-End Labeling; Mice; Nitriles; Phosphorylcholine; Reactive Oxygen Species; Signal Transduction; Sphingosine; Transfection | 2007 |
Sphingosylphosphorylcholine stimulates expression of fibronectin through TGF-beta1-Smad-dependent mechanism in human mesenchymal stem cells.
Topics: Adult; Benzamides; Blotting, Western; Butadienes; Cell Adhesion; Cells, Cultured; Dioxoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fibronectins; Gene Expression; Humans; Male; Mesenchymal Stem Cells; Middle Aged; Nitriles; Phosphorylation; Phosphorylcholine; Receptors, Transforming Growth Factor beta; RNA, Small Interfering; Smad Proteins; Smad7 Protein; Sphingosine; Transforming Growth Factor beta1 | 2007 |
MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition.
Topics: AMP-Activated Protein Kinases; Breast Neoplasms; Butadienes; Cell Line, Tumor; Glycolysis; Humans; Magnetic Resonance Spectroscopy; Male; Melanoma; Mitogen-Activated Protein Kinase Kinases; Nitriles; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Prostatic Neoplasms; Protein Kinase Inhibitors | 2014 |
c-Src activity is differentially required by cancer cell motility modes.
Topics: Actins; Amino Acid Substitution; Butadienes; Cell Adhesion; Cell Movement; Dasatinib; Humans; Imidazoles; Mutant Proteins; Neoplasms; Nitriles; Phosphorylcholine; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Quinolines; Tumor Cells, Cultured | 2018 |